Fosmanogepix is under investigation in clinical trial NCT03604705 (An Efficacy and Safety Study of APX001 in Non-Neutropenic Patients With Candidemia).
Inland Empire Liver Foundation, Rialto, California, United States
Genesis Clinical Research, LLC, Tampa, Florida, United States
Washington University School of Medicine, Infectious Diseases Clinical Research Unit, Saint Louis, Missouri, United States
University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States
Houston Methodist Hospital - Texas Medical Center, Houston, Texas, United States
CHU UCL Namur - Mont- Godinne University Hospital - Intensive Care Unit, Yvoir, Belgium
Cliniques Universitaires de Bruxelles Hôpital Erasme - Department of Infectious Diseases, Brussels, Belgium
Klinikum Neuperlach, Klinik fur Hamatologie und Onkologie, Munchen, Bavaria, Germany
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.